INKT vs INMB
Comparison between MiNK Therapeutics Inc (INKT, Company) and INmune Bio Inc (INMB, Company).
Both INKT and INMB are from the Healthcare sector.
5-Year PerformanceINMB has outperformed INKT, delivering a return of -39.4% compared to -40.2%
INKT vs INMB - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
INKT vs INMB - Historical Returns
Returns include dividend reinvestment.
INKT vs INMB - Annual Returns (2019 - 2026)
Returns include dividend reinvestment.
| Year | INKT | INMB |
|---|---|---|
| 2026 | -6.83% | +11.69% |
| 2025 | +10.40% | -68.36% |
| 2024 | -36.06% | -58.38% |
| 2023 | -58.53% | +67.81% |
| 2022 | -45.05% | -40.69% |
| 2021 | -62.83% | -42.24% |
| 2020 | N/A | +179.86% |
| 2019 | N/A | -27.41% |
INKT vs INMB Drawdown Comparison
The maximum drawdown for INKT was -97.69%, occurring on Dec 18, 2024. This drawdown has not yet recovered.
The maximum drawdown for INMB was -95.98%, occurring on Mar 27, 2026. This drawdown has not yet recovered.
The current INKT drawdown is -94.83%. The current INMB drawdown is -93.82%.
| Rank | INKT | INMB |
|---|---|---|
| #1 | -97.69% Nov 11, 2021 - Dec 18, 2024 | -95.98% Sep 7, 2021 - Mar 27, 2026 |
| #2 | -12.71% Nov 2, 2021 - Nov 11, 2021 | -79.91% May 9, 2019 - Jul 14, 2020 |
| #3 | -4.77% Oct 21, 2021 - Oct 27, 2021 | -65.40% Jan 19, 2021 - Sep 7, 2021 |
| #4 | -2.50% Oct 15, 2021 - Oct 19, 2021 | -52.32% Jul 14, 2020 - Dec 31, 2020 |
| #5 | N/A | -13.66% Feb 22, 2019 - Apr 8, 2019 |
| #6 | N/A | -9.29% Feb 4, 2019 - Feb 22, 2019 |
| #7 | N/A | -8.60% Apr 10, 2019 - Apr 22, 2019 |
| #8 | N/A | -5.83% Jan 6, 2021 - Jan 11, 2021 |
| #9 | N/A | -4.14% Apr 22, 2019 - May 1, 2019 |
| #10 | N/A | -4.11% May 2, 2019 - May 9, 2019 |
| #11 | N/A | -0.40% Jan 14, 2021 - Jan 19, 2021 |
| #12 | N/A | -0.23% Jan 11, 2021 - Jan 13, 2021 |
Correlation
Correlation between INKT and INMB is 0.51 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks